Revolutionary AI device utilizes few-molecule reservoir computing for blood glucose prediction

A collaborative research team from NIMS and Tokyo University of Science has successfully developed a cutting-edge artificial intelligence (AI) device that executes brain-like information processing through few-molecule reservoir computing. This innovation utilizes the molecular vibrations of a select number of organic molecules. By applying this device for the blood glucose level prediction in patients with diabetes, it has significantly outperformed existing AI devices in terms of prediction accuracy.

With the expansion of machine learning applications in various industries, there's an escalating demand for AI devices that are not only highly computational but also feature low-power consumption and miniaturization. Research has shifted towards physical reservoir computing, leveraging physical phenomena presented by materials and devices for neural information processing. One challenge that remains is the relatively large size of the existing materials and devices.

Our research has pioneered the world's first implementation of physical reservoir computing that operates on the principle of surface-enhanced Raman scattering, harnessing the molecular vibrations of merely a few organic molecules. The information is inputted through ion-gating, which modulates the adsorption of hydrogen ions onto organic molecules (p-mercaptobenzoic acid, pMBA) by applying voltage. The changes in molecular vibrations of the pMBA molecules, which vary with hydrogen ion adsorption, serve the function of memory and nonlinear waveform transformation for calculation. This process, using a sparse assembly of pMBA molecules, has learned approximately 20 hours of a diabetic patient's blood glucose level changes and managed to predict subsequent fluctuations over the next 5 minutes with an error reduction of about 50% compared to the highest accuracy achieved by similar devices to date.

The outcome of this study indicates that a minimal quantity of organic molecules can effectively perform computations comparable to a computer. This technological breakthrough of conducting sophisticated information processing with minimal materials and in tiny spaces presents substantial practical benefits. It paves the way for the creation of low-power AI terminal devices that can be integrated with a variety of sensors, opening avenues for broad industrial use.

The research initiative was spearheaded by Daiki Nishioka, serving as a Trainee in Ionic Devices Group at NIMS, Research Center for Materials Nanoarchitectonics (MANA), who is also a Japan Society for the Promotion of Science (JSPS) Research Fellow at Tokyo University of Science, and Takashi Tsuchiya, Principal Researcher, and Kazuya Terabe, Group Leader, both part of Ionic Devices Group at MANA, NIMS. This project is a segment of the "Nano Materials for New Principle Devices," supervised by Yoshihiro Iwasa, and is focused on the "Creation of Ultrafast Iontronics" under the auspices of JST PRESTO (JPMJPR23H4).

The findings of this research was published online in the Science Advances journal at 4 a.m. Japan time on February 29, 2024.

Source:
Journal reference:

Nishioka, D., et al. (2024). Few- and single-molecule reservoir computing experimentally demonstrated with surface-enhanced Raman scattering and ion gating. Science Advances. doi.org/10.1126/sciadv.adk6438.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New glucose-sensitive insulin NNC2215 could transform diabetes care by lowering hypoglycemia risk